20 Apr 2020 07:00
Sensyne Health launches CVm-Health™ 'Good Neighbour' app
New COVID-19 software application to help people monitor their own health and support members of the community most in need
Highlights:
· CVm-HealthÔ is a free, easy to use web-based software application available to anyone in the UK
· Enables the recording of health conditions, symptoms, vital signs and medications
· Creates the ability to immediately volunteer and build a community and be a 'good neighbour' for people without access to the internet
· Builds on Sensyne Health's previously launched remote patient monitoring systems such as GDm-HealthÔ in pregnant women and the vital signs monitoring system, SENDÔ
· CVm-Health is part of a broader strategy by Sensyne Health to provide a platform that enables the delivery of care to patients remotely
· CVm-Health is available to use at www.CVm-Health.com
Oxford, U.K. 20 April 2020: Sensyne Health plc (LSE: SENS) ("Sensyne" or the "Company" or the "Group"), the UK Clinical AI technology company, today announced the launch of a new web-based COVID-19 focused software application called 'CVm-HealthÔ the 'Good Neighbour app'. The app marks Sensyne Health's first direct to consumer software application built on its new SensyneOS Clinical AI platform. This platform is built to be globally scalable, with the highest levels of cyber security and regulatory compliance.
CVm-Health the Good Neighbour app - launched today
The app is free to anyone in the UK, and provides a secure way for individuals and families, sick or well, to monitor and support the management of their health for COVID-19 related symptoms.
The app will also enable individuals to 'be a good neighbour' by helping remotely monitor and care for members of their family or community who are at risk from Coronavirus and digitally disconnected, either those with poor technology literacy or without access to the internet. The Office of National Statistics has reported that 11.3 million people in the UK lack the basic digital skills needed to use the internet effectively, while 4.8 million people never go online at all.
Sensyne will work to build and engage with communities and aims to work alongside national and local charities and volunteer organisations.
Key features of CVm-Health are:
· Health monitoring
Enables individuals to remotely monitor their own and other people's vital signs (e.g. pulse, temperature), COVID-19 related symptoms and log existing health conditions and medications
· Good Neighbour care
To be used for those in the community that will remain at risk, isolated and locked-down after general social distancing guidance is relaxed
· Healthcare focussed
Built using Sensyne's expertise in developing validated digital health software products for the NHS that support healthcare specialists and patients in need
· Accessible to all
A web-based application which provides the greatest accessibility and the ability to rapidly add to and update features
· Rigorous data and regulatory compliance
Will not track location or share personal information. Fully GDPR and ISO compliant.
CVm-Health the Good Neighbour app - in the near future
The app has been built on a globally scalable and highly secure platform. The app will be made available outside the UK in due course. Over the coming weeks, Sensyne Health plans to add additional features to CVm-Health such as:
· provide reference information to enable individuals who are self-monitoring or monitoring members of their family or community in making informed decisions based on the latest medical guidance and their own symptom data recorded in the app
· a symptom and vital signs history view to help people monitor their health and create a COVID-19 digital diary
· the sharing of symptoms and vital signs history with healthcare professionals, family members and carers
With the consent of users, data generated by the application will be anonymised and analysed using sophisticated machine learning techniques to derive insights that will be made available free to the NHS and for medical research into the prevention, diagnosis and treatment of COVID-19.
CVm-Health builds on Sensyne Health's track record in developing validated digital health software products, such as its award-winning diabetes in pregnancy app GDm-Health™ and vital signs monitoring system SEND™, and in applying machine learning and AI to anonymised patient data to support clinical decision-making and medical research.
Sensyne recently made its GDm-Health app available free to all NHS Trusts in the UK for one year, to assist with monitoring and managing this high-risk group during the COVID-19 pandemic, and relieve pressure on the NHS.
Lord (Paul) Drayson, CEO of Sensyne Health, said:
"Current social distancing and self-isolation advice is limiting people's ability to care for the ones we love. While physical isolation during the crisis makes sense, social isolation doesn't. In line with Sensyne's aim to improve patient care, I hope CVm-Health becomes an app for everyone, including the digitally disconnected, and enables people to volunteer, from their laptop on their sofa, or at a safe distance in their neighborhood, to help look after those most vulnerable in society."
Brian McKinstry, Emeritus Professor of Primary Care E-Health at the University of Edinburgh, and co-Chair of the independent CVm-Health Clinical Leadership Board, said:
"Not everyone has access to or is able to use a smartphone or computer and as a result such people are unable to take advantage of many apps. This app allows family members or friends to help such people record their symptoms in a logical way that will help doctors and nurses look after them during the Coronavirus pandemic."
Dr Chris Paton, Head of the Global Health Informatics Group at the University of Oxford, and co-Chair of the independent CVm-Health Clinical Leadership Board, said:
"This app will be especially useful for those who want to help look after their family members or neighbours who might not have access to smartphones or tablet computers themselves. The app provides a simple and effective way of helping people track their own and others symptoms over time while ensuring the data collected is securely protected so that it can be used to help doctors and the NHS manage the Coronavirus pandemic."
-ENDS-
For more information please contact:
Sensyne Health (www.sensynehealth.com) | +44 (0) 330 058 1845 |
Lord (Paul) Drayson PhD FREng, Chief Executive Officer | |
Michael Norris, Interim Chief Financial Officer | |
Peel Hunt LLP (Nominated Adviser and Joint Broker) |
+ 44 (0) 20 7418 8900 |
Dr Christopher Golden | |
James Steel | |
Oliver Jackson | |
Liberum (Joint Broker) | + 44 (0) 20 3100 2000 |
Bidhi Bhoma | |
Euan Brown | |
Consilium Strategic Communications | +44 (0) 7780 600290 |
Mary-Jane Elliott | |
Sukaina Virji | |
Melissa Gardiner | |
sensynehealth@consilium-comms.com |
About Sensyne Health
Sensyne Health plc is a clinical AI company that works in partnership with the NHS to improve patient care and accelerate the discovery and development of new medicines. Sensyne Health is listed on the AIM Market of the London Stock Exchange (SENS.L).
For more information, please visit: www.sensynehealth.com